Companies › ATRC

ATRICURE INC (ATRC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001323885 · EDGAR filings · Updated 2026-07-28

ATRICURE INC (ATRC) has reported institutional ownership of 98.3%, with 222 institutional managers holding positions valued at $1.46B per the latest 13F reporting period.

Filings this week (6)

• 2026-07-28 — Notice of proposed sale filed (Form 144)
• 2026-07-28 — Notice of proposed sale filed (Form 144)
• 2026-07-27 — Employee-plan registration (S-8) filed
• 2026-07-27 — Employee-plan registration (S-8) filed
• 2026-07-27 — Quarterly report (10-Q) filed
• 2026-07-23 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ATRICURE INC has 222 institutional holders and institutional ownership of 98.3%.

Insider activity

Insiders reported 57 transactions (0 buys, 11 sells) across 15 reporting insiders, with a net reported value of −$1.56M.

Related companies

ORIC PHARMACEUTICALS INC (ORIC) · TANDEM DIABETES CARE INC COM NEW (TNDM) · DEFINIUM THERAPEUTICS F (DFTX) · DAMORA THERAPEUTICS INC (DMRA) · MONTE ROSA THERAPEUTICS INC (GLUE) · BELITE BIO INC (BLTE)